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ABSTRACT
Bone can adapt its structure in response tomechanical stimuli. At the cellular level, this involves changes in chromatin organization, gene
expression, and differentiation, but the underlying mechanisms are poorly understood. Here we report on the involvement of RUNX2,
a bone-related transcription factor, in this process. Fluid flow shear stress loading of preosteoblasts stimulated translocation of
extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) to the nucleus where it phosphorylated RUNX2 on
the chromatin of target genes, and increased histone acetylation and gene expression. MAPK signaling and two RUNX2 phosphoac-
ceptor sites, S301 and S319, were critical for this response. Similarly, in vivo loading of mouse ulnae dramatically increased ERK and
RUNX2 phosphorylation as well as expression of osteoblast-related genes. These findings establish ERK/MAPK-mediated phosphoryla-
tion of RUNX2 as a critical step in the response of preosteoblasts to dynamic loading and define a novel mechanism to explain how
mechanical signals induce gene expression in bone.  2012 American Society for Bone and Mineral Research.
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Introduction
Bone has the unique ability to modify its structure in responseto changes in skeletal loading. Classic examples are
the increase in skeletal mass associated with weight-bearing
exercise,(1) elevated bone mass in loaded bones of elite
athletes,(2) and conversely, dramatic losses in bone density
associated with bed rest and space flight.(3,4) The anabolic effects
of mechanical loading are comparable to or greater than
humoral factors such as parathyroid hormone, yet remain poorly
understood.
Loading of bone causes movement of interstitial fluid through
channels within the bone structure (canaliculi) and marrow
spaces, thereby generating fluid flow shear stress (FFSS)(4)
across the surface of bone cells(for reviews, see Robling and
colleagues(5) and Rubin and colleagues(6)). All cells in the
osteoblast lineage (mesenchymal stem cells/marrow stromal
cells, preosteoblasts, osteoblasts, and osteocytes) respond to
FFSS in vitro, and may contribute to the overall anabolic
response of bone during in vivo loading.(6) FFSS stimulates
integrin-mediated activation of focal adhesion kinase (FAK),
a component of the focal adhesions that link cells with their
extracellular matrix.(7–9) Focal adhesions are proposed to
function as primary mechanosensors, linking shear forces
induced by fluid flow with cytoplasmic signaling pathways.
FAK activates extracellular signal-regulated kinase (ERK), p38,
and c-Jun N-terminal kinase (JNK) mitogen-activated protein
kinase (MAPK) as well as the phosphatidylinositol 3-kinase (PI3K)/
protein kinase B (AKT) pathways,(10,11) and is necessary for
subsequent induction of downstream mechanoresponsive
genes such as secreted phosphoprotein 1 (Spp-1), c-fos, and
cyclooxygenase-2 (COX-2).(9) Moreover, conditional deletion of
FAK in osteoblasts renders mice resistant to the anabolic effects
of local mechanical loading.(12)
Early FFSS-induced membrane changes ultimately stimulate
the differentiation of osteoblasts from mesenchymal precursors,
leading to new bone formation.(13,14) An outstanding question
relates to how these early signals translate into the global
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changes in nuclear activity, chromatin structure, and gene
expression necessary for new bone formation. The RUNX2
transcription factor is ideally positioned to link cell surface signals
with the nucleus. RUNX2 is required for osteoblast-specific gene
expression and differentiation of mesenchymal progenitor cells
to osteoblasts during development as well as in adult life.(15)
It functions by associating with specific enhancers in the
regulatory regions of target genes such as osteocalcin (Bglap2),
bone sialoprotein (Ibsp), and osteopontin (SPP-1),(16,17) where it
recruits other nuclear components to the transcriptional
apparatus.(18) RUNX2 functions broadly throughout osteoblast
development and is tightly controlled by both posttranslational
modifications and interactions with other nuclear proteins.(19)
Notably, RUNX2 is regulated by ERK1/2 and p38 MAPK-mediated
phosphorylation during osteoblast differentiation, making
it an attractive candidate to mediate effects of FFSS on
transcription.(20–22) In vivo studies also suggest possible
involvement of RUNX2 in bone mechanoresponsiveness, in that
Runx2 heterozygous-null mice are resistant to the bone loss
associated with skeletal unloading.(23)
Here we identify a mechanism to explain how mechanical
loading regulates gene expression in bone. As we show,
exposure of preosteoblast cells to FFSS or in vivo loading of
mouse ulna stimulates ERK/MAPK-dependent phosphorylation
of RUNX2 at specific serine residues. This is accomplished by
nuclear translocation and docking of activated ERK to RUNX2
previously associated with the chromatin of target genes. MAPK
activity and RUNX2 phosphorylation are required for subsequent
changes in histone acetylation and gene expression. This
mechanism provides a route for a biomechanical signal to be
dispersed to RUNX2-regulated genes, resulting in the global
changes in gene expression necessary for new bone formation.
Materials and Methods
Reagents
The reagents used in this study were from the following sources:
tissue culture medium and fetal bovine serum from Hyclone
Laboratories (Logan, UT, USA) and Invitrogen (Carlsbad, CA, USA),
RUNX2 antibody fromMedical & Biological Laboratories (Nagoya,
Japan; catalog number D130-3), P-ERK and total ERK antibodies
from Cell Signaling Technology (Beverly, MA, USA; catalog
numbers 9101 and 9102), acetylated histone H3 and H4 and
histone H3 phosphorylated at serine 10 from Millipore (Billerica,
MA, USA; catalog numbers 17-615, 17-630, and 06-570), and
sheep anti-mouse or donkey anti-rabbit immunoglobulin G
(IgG) conjugated with horseradish peroxidase (HRP) from GE
Healthcare (Piscataway, NJ, USA).
Generation of a phospho-RUNX2–specific antibody
An antibody that specifically detects RUNX2 phosphorylated at
S319 was produced by Covance (Princeton, NJ, USA) using the
following peptide as immunogen: YPSYLSQIMTS(P)PSIHSTTPL.
The specificity of this antibody for RUNX2-S319-P has been
described.(24) This antibody is specific for RUNX2-S319-P and
does not cross-react with any other runt-related transcription
factor.
Cell culture
We maintained MC3T3 subclone 42 preosteoblast cells in
a-Minimal Essential Medium (a-MEM; Life Technologies, Inc.,
Grand Island, NY, USA) supplemented with 10% fetal bovine
serum (FBS; Hyclone Laboratories) and 1% penicillin/streptomy-
cin as described.(25) These cells contain stably integrated copies
of a 1.3-kb murine mOG2-luc reporter gene derived from Bglap2.
C3H10T1/2 cells were obtained from the American Type Culture
Collection (Manassas, VA, USA) and maintained in DMEM, 10%
FBS.
Viral transduction
We prepared adenoviruses expressing wild-type RUNX2 or
RUNX2 containing S301A, S319A mutations and used them to
transduce C3H10T1/2 cells as described.(21) Cells were exposed
to FFSS 24 hours after viral transduction.
FFSS loading
We plated the cells on glass microscope slides (75 38 1mm)
precoated with 0.005% poly-L-Lysine (Sigma, St. Louis, MO, USA)
at a density of 50,000/cm2. After 12 hours, cells were exposed to
oscillatory FFSS using a pulse-static waveform (0.033Hz at 2 Pa,
15 seconds forward, 15 seconds reverse with a 0.2-second
transition) for increasing times up to 1 hour using a custom-
designed system similar to those described.(26) This system
exposed cells to laminar flow resulting in a shear stress of 15 to
20 dynes/cm2. To maintain constant conditions before, during,
and after exposure to FFSS, we took care to keep cells in the
same medium throughout the experiment (no medium changes
were included). For static controls, cells were maintained under
identical conditions, but without FFSS.
RNA isolation and RT-PCR
We isolated total RNA using Trizol reagent (Invitrogen) with an
RNeasy Mini Kit (Qiagen, Valencia, CA, USA). Two micrograms
of total RNA was reverse-transcribed using TaqMan reverse
transcriptase (Applied Biosystems, Inc., Foster City, CA, USA)
for cDNA synthesis. Quantitative real-time polymerase chain
reaction (PCR) detection of Bglap2, Ibsp, SPP-1, Runx2, and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNAs
was carried out, as described,(27) using predeveloped TaqMan
probes and an ABI PRISM 7700 sequence detector (Applied
Biosystems). The mRNA expression for each gene of interest was
calculated based on a relative standard curve and normalized to
GAPDH mRNA.
Western blots and immunoprecipitation
We harvested the cells in high-salt radioimmunoprecipitation
assay (RIPA) lysis buffer (10mM Tris, 5mM EDTA, 0.25% Triton
X-100, 300mM NaCI, phenylmethylsulfonyl fluoride (PMSF),
1proteinase inhibitor cocktail; Sigma). Total protein concen-
tration was measured with a Bio-Rad protein assay kit (Bio-Rad
Laboratories, Hercules, CA, USA). Equal aliquots of protein were
fractioned by SDS-PAGE using 4% to 20% Tris-Glycine gels. After
transfer to nitrocellulose membranes, samples were incubated
overnight at 48C with the indicated antibodies: RUNX2 (1:500
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dilution), P-ERK antibody (1:500 dilution), RUNX2-S319-P (1:1000
dilution), acetylated histone H3 and H4 (1:2000 dilution), and
phosphorylated histone H3 S10-P (1:1000). A second antibody
(sheep anti-mouse or donkey anti-rabbit conjugated with HRP
was used at 1:10,000 dilution. HRP was detected by enhanced
chemiluminescence (ECL) (Amersham Biosciences, Piscataway,
NJ, USA). For certain experiments, P-RUNX2 was detected in
cell extracts by immunoprecipitation using anti-RUNX2-S319
antibody followed by Western blot detection of total RUNX2.
Immunofluorescence
We carried out immunofluorescence as described.(27) Cells were
fixed with 4% formaldehyde for 10 minutes at room temperature
and then incubated overnight at 48C with primary antibodies to
Runx2 (1:100 dilution), P-ERK (1:100 dilution), P-Runx2 (1:500
dilution), acetylated histone H3 and H4 (1:500 dilution), and
Serine 10 phosphorylated histone H3 (1:300 dilution). After
incubation in Alexa Fluor 488 conjugated donkey anti-mouse
and Alexa Fluor 555 conjugated donkey anti-rabbit (Invitrogen)
antibodies, fluorescence was detected using an Olympus
FluoView 500 laser scanning confocal microscope system
with a 100 oil-immersion objective at room temperature
(Microscopy and Image Analysis Laboratory, University of
Michigan School of Medicine).
Chromatin immunoprecipitation
We performed chromatin immunoprecipitation (ChIP) assays as
described.(17) Briefly, after FFSS, cells were cross-linked with 1%
p-formaldehyde for 10 minutes at room temperature. Chromatin
was then isolated and sheared by sonication to produce an
average fragment size of 300 to 500 bp. Chromatin (10mg DNA/
assay) was precleared by incubation with protein A/G agarose
beads (Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 1 hour,
incubated with primary antibodies, and precipitated with A/G
agarose beads. After purification with a nucleic acid removal kit
(Qiagen), input and precipitated DNA were analyzed by PCR (35
cycles) or by quantitative real-time PCR using TaqMan probes
flanking OSE2a, OSE2b, or control transcribed regions in the
Bglap2 gene. PCR primers were designed to detect OSE2a and
OSE2b regions of the Bglap2 promoter (160 to 120 bp and
620 to 580 bp, respectively), coding sequence in the first
exon of Bglap2, a functional RUNX2 binding region in Ibsp (130
to 59 bp), and a nonfunctional consensus RUNX2 binding
region in Ibsp (1300 to 1200 bp). All PCR primer sequences
used for ChIP analysis were previously described: Bglap2(28) and
Ibsp.(17)
In vivo mechanical loading
We used an ulnar loading model and custom equipment built at
the University of Michigan School of Medicine for the in vivo
mechanical loading studies. This loading system is based upon
work by Lee and colleagues.(29) All studies with mice were
performed in compliance with the University of Michigan
Committee for the Use and Care of Animals. The left forelimbs of
male C57BL6 mice (16 weeks of age) were uniaxially loaded to
a peak compressive force of 1.3 N (generates approximately
2000 micro-strain at the ulnar mid-diaphysis), 500 cycles/d
(sinusoidal waveform at 2Hz) for 1, 2, or 3 days (n¼ 6 per group).
Ten minutes after the start of each loading cycle, right and left
limbs were harvested under sterile conditions and used for
the analysis of mRNA and protein. For RNA isolation, ulnae were
stripped of outer connective tissue and whole bones were
ground in liquid nitrogen with a mortar and pestle. The powder
thenwas resuspended in Trizol reagent (Invitrogen) and RNAwas
isolated.
For protein extraction and immunoprecipitation, whole
ulnae were homogenized in high-salt RIPA buffer using a
Polytron homogenizer. After centrifugation, the supernatant
was directly separated on 4% to 20% SDS-PAGE or used in
immunoprecipitation reactions.
Statistical analysis
Results are presented as mean SE. Sample size is indicated in
the legend for each figure. Statistical significance was assessed
using a one-way ANOVA followed by Tukey’s multiple-comparison
test. All experiments were repeated at least twice.
Results
FFSS loading rapidly stimulates ERK/MAPK-mediated
RUNX2 phosphorylation and transcriptional activity
We used MC3T3-E1 clone 42 cells, a well-characterized
preosteoblast cell line, to examine early effects of FFSS on
osteoblast gene expression and signaling. These cells contain
stably integrated copies of the murine Bglap2 promoter driving
luciferase (1.3-kb mOG2-luc), making them useful both to
measure transcription driven by an osteoblast-related gene
promoter as well as mRNA induction. Previous studies
established a good correlation between mOG2-luc activity and
gene expression during in vitro osteoblast differentiation.(25)
Clone 42 cells were exposed to oscillating FFSS for up to 1 hour
and then cultured under static conditions for up to an additional
12 hours. FFSS rapidly stimulated transcription of the mOG2-luc
reporter gene, with significant increases in luciferase activity
seen after 1 hour. This FFSS stimulation persisted through the 12-
hour time point (Fig. 1A). These changes were accompanied by
increases in several osteoblast-related mRNAs (Bglap2, Ibsp, and
SPP-1). FFSS induced Bglap2mRNA twofold after 2 hours and this
induction increased to approximately fourfold after 12 hours
(Fig. 1B). Similarly, Ibsp mRNA induction was first seen after
2 hours (fourfold) and continued to increase at 6 and 12 hours
(approximately 10-fold induction at both times; Fig. 1C). Spp1
mRNA was induced most rapidly, with peak levels seen after
1 and 6 hours (fivefold induction) followed by a drop 12 hours
after FFSS (Fig. 1D). In contrast, Runx2 mRNA levels did not
significantly change over this time interval (Fig. 1E).
Integrin/focal adhesion kinase activation of the ERK/MAPK
pathway is a well-characterized response to FFSS.(9) Furthermore,
the terminal MAPK in this pathway, ERK1/2, was recently shown
to stimulate RUNX2-dependent transcriptional activity by
directly phosphorylating RUNX2 on specific serine residues
(S43, S301, S319, and S510). Of these, both S301 and S319
were shown to be critical for transcriptional activation during
osteoblast differentiation. Specifically, whereas individual S301A
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or S319A mutations had only a small effect on RUNX2
transcriptional activity, combined mutation of both sites almost
completely blocked the ability of RUNX2 to stimulate transcrip-
tion of osteoblast-related genes during in vitro osteoblast
differentiation.(21) To determine if this pathway is important for
FFSS induction of osteoblast gene expression, we examined ERK
and RUNX2 phosphorylation (Fig. 2A and Supplementary Fig. S1).
These studies used a unique antibody that specifically detects
phosphorylation of RUNX2 at S319. Previous studies showed that
phosphorylation at this site is well-correlated with transcriptional
activity stimulated by both ERK1/2 and p38 MAPKs.(21,24) FFSS
rapidly stimulated both ERK and RUNX2–S319 phosphorylation.
A more detailed time course study revealed that both phosphory-
lation events could be detected after as little as 5 minutes of FFSS,
gradually declined, and then increased again at later times
(Supplementary Fig. S1). No changes in p38 phosphorylation were
detected under these conditions (data not shown).
We next used immunofluorescence confocal microscopy
to examine the effect of FFSS on the subcellular localization
of P-ERK and RUNX2 (Fig. 2B, C shows high-magnification images
of single representative cells, whereas Supplementary Figs. S2
and S3 show low-power fields). In the unstimulated state, P-ERK
had a cytoplasmic/perinuclear localization whereas RUNX2
remained exclusively nuclear under all conditions. However,
only very faint P-RUNX2 staining was seen in unstimulated cells.
FFSS rapidly increased the nuclear localization of P-ERK without
affecting total RUNX2 distribution. Furthermore, FFSS strongly
stimulated nuclear P-RUNX2 immunofluorescence. Interestingly,
merger of P-ERK and RUNX2 images suggests possible nuclear
colocalization of these two molecules. Furthermore, extensive
colocalization of P-RUNX2 with total RUNX2 was observed, as
would be expected.
FFSS stimulates P-ERK binding to chromatin-associated
RUNX2 and RUNX2 phosphorylation
RUNX2 regulates transcription by binding to specific enhancer
sequences in the regulatory regions of target genes.(16) During
Fig. 1. FFSS induction of osteoblast gene expression. MC3T3-E1 cl42 preosteoblast cells weremaintained as static cultures or exposed to FFSS for 0, 0.5, or
1 hour as described in Materials and Methods. Cells were either harvested immediately after FFSS or exposed to FFSS for 1 hour and cultured for an
additional 2, 6, or 12 hours as indicated. Cells were assayed for Bglap2 promoter activity (luciferase) (A) or mRNA levels for SPP-1 (B), Bglap2 (C), Ibsp (D), and
Runx2 (E). All mRNA values were normalized to GAPDH mRNA, which was not affected by FFSS. Significantly different from time-matched static control,
p< 0.01, n¼ 3.
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osteoblast differentiation, P-ERK binds to chromatin-associated
RUNX2 via a specific docking or ‘‘D site’’ in the C terminal
portion of the runt domain.(21,27) This docking event is necessary
for subsequent phosphorylation and activation of RUNX2.(21,24)
On the basis of this background, studies were carried out to
assess whether FFSS could stimulate P-ERK-RUNX2 binding
and phosphorylation on target gene chromatin (Fig. 2D, E).
ChIP assays were conducted with antibodies to total RUNX2,
RUNX2-S319-P, P-ERK, and isotype-matched IgG (negative
control), using PCR primers to detect association of each factor
with RUNX2 enhancers in the proximal promoter regions of
Bglap2 and Ibsp.(27) For Bglap2 ChIP analysis, binding near
OSE2a (130 bp) and OSE2b (605 bp) promoter regions was
separately analyzed; whereas for Ibsp, binding was examined
at overlapping RUNX2 binding sites at 130 bp and at a
nonfunctional site at 1300 bp (negative control). As a further
control, binding to transcribed regions in the first exon of each
gene was also examined and found to be negative (data not
shown). In unstimulated cells, RUNX2 was bound to Bglap2
and Ibsp chromatin and this binding remained relatively
constant after FFSS. In contrast, chromatin-associated P-ERK
and P-RUNX2 were low to undetectable in control cells, but
dramatically increased with FFSS. This is consistent with the
concept that, after nuclear translocation, P-ERK binds and
phosphorylates RUNX2 previously associated with target gene
chromatin.
FFSS-related changes in histone acetylation and
phosphorylation
In eukaryotic cells, chromatin must progress from a condensed,
inactive state to an open, active conformation before genes can
be expressed.(30) The state of histone acetylation and related
histone phosphorylation are major determinants of chromatin
decondensation and transcriptional activity.(31) Histone H3 S10
phosphorylation was previously associated with the response
to mitogenic and differentiation signals stimulated by growth
factors and, in some cases, was shown to be required for
subsequent histone acetyltransferase activation.(32,33) Histone H3
and H4 acetylation, particularly at K9 and K14, is selectively
associated with chromatin decondensation and increased
transcription.(34) As shown in Figure 3, FFSS increases both
types of histone posttranslational modification. This was shown
using Western blot detection of histones in whole-cell extracts
(Fig. 3A), immunofluorescence (Fig. 3B–D), and ChIP analysis of
RUNX2-binding regions of both Bglap2 and Ibsp (Fig. 3E, F). The
immunofluorescence colocalization of RUNX2 with modified
histones as well as ChIP analysis suggest that histone
modifications occurred in regions of chromatin proximal to
Fig. 2. FFSS rapidly stimulates ERK1/2 activity, nuclear translocation, chromatin binding, and RUNX2 phosphorylation. (A) FFSS stimulates ERK/MAPK and
RUNX2-S319 phosphorylation. Cell lysates were analyzed by probingWestern blots with the indicated antibodies, except in the case of P-RUNX2 for which
P-RUNX2 antibodywas used for immunoprecipitation followed byWestern blot detection of total RUNX2. (B,C) FFSS increases nuclear localization of P-ERK,
Runx2, and P-Runx2. Immunofluorescence confocal microscopy was used to localize the indicated factors. FFSS stimulated the translocation of P-ERK from
a perinuclear cytoplasmic compartment to the nucleus without affecting the nuclear localization of RUNX2 in B, and increased nuclear RUNX2-S319-P in C.
Note colocalization of P-ERK and RUNX2 (in B, merged image) and P-RUNX2 with total RUNX2 (inC, merged image). Bar¼ 5mm. Low-power views of
multiple cells are shown in Supplementary Figs. S2 and S3. (D,E) FFSS stimulates binding of P-ERK and P-RUNX2 to proximal promoter regions of Bglap2 and
Ibsp chromatin. ChIP assays were used to measure chromatin-bound RUNX2, P-RUNX2, and P-ERK1/2. Nonspecifically precipitated chromatin was
measured using isotype-matched IgG. PCR primers were designed to detect OSE2a and OSE2b regions of the Bglap2 gene in D, and proximal and distal
(nonfunctional) RUNX2 binding sites in Ibsp in E.
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the bound RUNX2. In contrast, no histone modifications were
detected using the distal Ibsp primers that amplify a region of
chromatin that is approximately 1200 bp away from the nearest
RUNX2 binding site (Fig. 3F).
FFSS-induced changes in chromatin structure and gene
expression require ERK/MAPK activity and RUNX2
phosphorylation
We next used chemical inhibition and genetic studies to examine
whether phosphorylation of RUNX2 by ERK is necessary for the
FFSS-induced changes described above. In the first study, cells
were pretreated with the MAPK inhibitor, U0126, before FFSS
(Fig. 4). MAPK inhibition totally blocked FFSS induction of Bglap2,
Ibsp, and SPP-1 mRNAs (Fig. 4A). Furthermore, this inhibitor
clearly blocked FFSS-dependent RUNX2-S319 phosphorylation
(Fig. 4B), translocation of P-ERK to RUNX2 binding regions
on Bglap2 chromatin (Fig. 4C), histone H3-S10 phosphorylation,
and histone H3/H4 acetylation (Fig. 4D). Significantly, MAPK
inhibition did not affect chromatin-bound RUNX2, indicating
that RUNX2 does not need to be phosphorylated to remain
chromatin-associated (Fig. 4C, right 2 lanes).
Fig. 3. FFSS stimulates histone acetylation and phosphorylation on chromatin of osteoblast target genes. (A) Total histone modification. Histones were
extracted from nuclei and total acetylated H3 and H4 as well as S10-phosphorylated H3 were measured on Western blots. (B–D) Colocalization
of acetylated/phosphorylated histones with RUNX2. Total RUNX2 and modified histones were localized by immunofluorescence confocal microscopy.
(E,F) FFSS stimulates histone modification near RUNX2-binding regions of Bglap2 and Ibsp. ChIP assays were conducted using the indicated antibodies
and primers to proximal promoter regions of Bglap2 and Ibsp as in Fig. 2.
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To more directly assess the specific role of RUNX phosphory-
lation in the FFSS response, adenovirus expressing wild-type
and S301A, S319A mutant RUNX2 were developed and used to
transduce C3H10T1/2 cells (Fig. 5). As previously shown, both
S301 and S319 are required for MAPK-dependent stimulation
of RUNX2 transcriptional activity; mutation of both these sites
blocks MAPK responsiveness whereas single mutations only
slightly reduce activity.(21) The pluripotent C3H10T1/2 mesenchy-
mal cell line normally does not express RUNX2, but undergoes
osteoblast differentiation after RUNX2 transfection.(27,35) Expo-
sure of control cells to FFSS did not affect the low basal levels of
Bglap2 and SPP-1 mRNA, although it did still stimulate ERK1/2
phosphorylation (data not shown). However, transduction with
wild-type RUNX2 adenovirus increased basal Bglap2 and SPP-1
mRNA in control cultures and rendered cells highly responsive to
FFSS. In contrast, cells transduced with the S301A, S319A double
mutant were refractory to FFSS stimulation. Note, however, that
mutant RUNX2 was still able to increase basal Bglap2 and SPP-1
Fig. 4. ERK1/2 MAP kinase activity is required for FFSS-induced RUNX2 phosphorylation, histone modifications, and gene expression. Cells were exposed
to FFSS for 1 hour in the presence or absence of MAPK inhibitor, U0126 (10mM), and were either immediately harvested for Western blot and ChIP analysis
(B–D) or cultured for an additional 12 hours for mRNA detection (A). (A) Gene expression. The indicated mRNAs were measured by real-time RT-PCR and
results were normalized to GAPDHmRNA. Significantly different from corresponding static control, ap< 0.05, bp< 0.01, n¼ 3. (B) ERK1/2 and RUNX2-S319
phosphorylation. (C,D) P-ERK binding to chromatin and histone modifications. ChIP assays were conducted as in Fig. 2 using primers to OSE2a and OSE2b
regions of the mOG2 promoter.
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mRNA levels. These results could not be explained by differences
in amounts of wild-type and mutant RUNX2 protein, which
were expressed to the same levels. Also and as expected,
FFSS stimulation of RUNX2-S319-P was only detected in cells
transduced with wild-type RUNX2 (see Western blot; Fig. 5A,
bottom). Cells expressing mutant RUNX2 also failed to exhibit
the FFSS-induced increases in chromatin-associated histone
acetylation and phosphorylation seen in wild-type cultures
(Fig. 5B). This underscores the importance of RUNX2-S301/S319
phosphorylation in the response of osteoblasts to FFSS.
Involvement of ERK1/2 and RUNX2 phosphorylation in
the in vivo response of bone to mechanical loading
We used a mouse ulnar loading model to examine ERK and
RUNX2 phosphorylation in vivo. The left forelimbs of male
C57BL6 mice were exposed to cyclical uniaxial compression
loading (500 cycles/d, 2 Hz) for 3 successive days. A similar
loading regimen was previously shown to increase total bone
formation rate after 2 weeks.(29) Immediately after each loading
period, a group of animals was euthanized for isolation of total
RNA and protein from whole bones. Small (twofold to threefold)
increases in Bglap2, Ibsp, and Spp-1mRNAs were detected after a
single loading cycle, and the magnitude of induction continued
to increase with each successive day such that fold inductions
from 15- to 30-fold were seen by day 3 (Fig. 6A). Similar to FFSS
results, RUNX2 mRNA levels remained relatively stable through-
out the experiment. Immunoprecipitation and Western blot
analysis of total bone protein extracts was used to measure ERK
and RUNX2-S319 phosphorylation. After a single loading cycle, a
clear increase in P-ERK was apparent. By cycle two, RUNX2-S319
phosphorylation was seen, and this persisted after the third day
Fig. 5. RUNX2 S301/S319 phosphorylation is required for downstream responses to FFSS. C3H10T1/2 cells were transduced with Lac Z control adenovirus
(Laz) or adenoviruses expressingwild-type RUNX2 or RUNX2 containing S301A/S319A doublemutations and, after 24 hours, exposed to FFSS for 1 hour. (A)
Gene expression. Bglap2 and SPP-1 mRNAs were measured by real-time RT-PCR 12 hours after FFSS and results were normalized to GAPDHmRNA. Bottom
panel shows Western blots of total and RUNX2-S319-P (arrow). Significantly different from corresponding RUNX2 static control (wild-type or mutant),
ap< 0.05, bp< 0.01, n¼ 3. (B) Histonemodifications. Cells were harvested for ChIP analysis immediately after FFSS. ChIP was conducted using antibodies to
acetylated histone H3 and H3 and S10-phosphorylated H3 and PCR primers to OSE2a and OSE2b regions of the mOG2 promoter.
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of loading. Because no attempt was made to fractionate bone
into marrow, endosteal, or periosteal compartments, it is not
possible to make any conclusions about which cell population is
responsible for these changes. Nevertheless, these results clearly
show that in vivo loading can induce the same changes in ERK/
MAPK signaling and RUNX2 phosphorylation seen after FFSS
exposure of preosteoblasts in cell culture.
Discussion
Here we describe a novel mechanism to explain how bone cells
modify chromatin structure and gene expression in response to
mechanical signals. Mechanical loading stimulates osteoblast
precursor cells through a number of mechanisms, including
FFSS. This stimulation activates the ERK/MAPK pathway, likely via
activation of FAK/integrin complexes in focal adhesions. Active
P-ERK1/2 translocates to the nucleus where it selectively
associates with RUNX2 bound to specific enhancer regions in
the regulatory regions of osteoblast target genes. P-ERK then
phosphorylates RUNX2 at S301 and S319, a necessary event for
subsequent changes in histone phosphorylation, acetylation,
chromatin decondensation, and transcription (see Fig. 7).
Substantial evidence was presented in support of this model.
Both ERK1/2 and RUNX2 S319 phosphorylation were shown to
rapidly (within 5 minutes) increase after the onset of FFSS. These
changes were accompanied by translocation of P-ERK from a
cytoplasmic/perinuclear compartment to the nucleus where it
was colocalized with RUNX2 as measured by immunofluores-
cence microscopy. This colocalization was also apparent on the
chromatin, where P-ERK bound to RUNX2 previously associated
with enhancer regions in the proximal promoters of Bglap2 and
Ibsp genes. Coincident with the nuclear translocation of P-ERK
was the appearance of phosphorylated RUNX2, phosphorylated
histone H3, and acetylated histones H3 and H4 in chromatin
Fig. 6. In vivo mechanical loading stimulates ERK/MAPK activity, RUNX2 phosphorylation, and osteoblast gene expression. C57BL6 mice were exposed
to 1, 2, or 3 days of ulnar loading. Loading was for 500 cycles at 2 Hz. Each day, bones were isolated 10 minutes after the loading cycle was completed and
RNA and protein were extracted as described in Materials and Methods. (A–D) Gene expression. Bglap2, Ibsp, SPP-1, and Runx2 mRNAs were measured by
real-time RT-PCR and results were normalized to GAPDHmRNA. Statistics: significantly different from time-matched unloaded control, ap< 0.05, bp< 0.01,
n¼ 6. (E) Western blot detection of ERK1/2 and RUNX2 S319 phosphorylation. Whole-bone extracts were immunoprecipitated with the indicated
antibodies.
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regions containing RUNX2-specific enhancers. Furthermore,
ERK/MAPK activity and RUNX2 S301 and S319 phosphorylation
sites were required for subsequent FFSS-induced changes in
histone acetylation and RUNX2-dependent transcription.
The changes in ERK and RUNX2 phosphorylation seen after
FFSS in cell culture were also detected after in vivo loading of
mouse ulnae. We observed that each successive period of in vivo
loading increased mRNA levels as well as P-ERK and RUNX2-S319
phosphorylation. This likely indicates activation of additional
osteoblasts precursor cells that will amplify the adaptive response.
Bone adaptation is known to be enhanced by repeated loading
periods interspersed with rest, which is due to a desensitization
of bone to continuous mechanical stimuli.(36) In addition, bone
will adapt little (if at all) to a single, short-term loading bout.(37)
Based upon the signaling/activation mechanism we proposed,
our in vivo data is consistent with previous bone adaptation
studies. However, because whole ulnae were used for isolation of
RNA and protein after loading, it is not possible to determine
which specific cell populations respond to in vivo loading by
increasing ERK and RUNX2 phosphorylation. Also, a definitive
demonstration that RUNX2 phosphorylation is required for in
vivo stimulation of gene expression by loading will require
studies with transgenic mice containing phosphorylation-
deficient RUNX2.
In order for mechanical loading to stimulate bone formation, a
mechanism is required to convert a mechanical signal into
biochemical changes capable of altering the pattern of gene
expression in bone progenitor cells. Because osteoblast
differentiation likely requires the reprogramming of a large
number of genes, cells must transfer a signal to the nucleus that
can be readily dispersed throughout the genome to selectively
alter the expression of only those genes necessary for the
osteoblast lineage. We propose that one such signal is P-ERK.
Multiple tissues, including blood vessels, bone, and muscle,
respond to FFSS at least in part via activation of the integrin/focal
adhesion/MAPK pathway, yet each cell type displays a unique
response to mechanical challenges. For example, in vascular
endothelial cells, exposure to FFSS induces genes that render the
endothelium resistant to proinflammatory cytokines and reduce
smooth muscle proliferation, whereas in pathological conditions
FFSS stimulates intimal thickening leading to atherosclerotic
plaque formation.(38) A different response is initiated in bone that
involves induction of a unique pattern of gene expression
necessary for osteoblast differentiation and mineralization.
How might a similar FFSS-induced signal have such different
effects on these two types of cells? We believe that the MAPK
activation of tissue-specific transcription factors described
here offers a way for mechanical loads to selectively activate
only those genes associated with a specific phenotype while
repressing genes involved in other lineages. This concept is
illustrated in Figure 5, where exposure of RUNX2-deficient
C3H10T1/2 cells to FFSS stimulated ERK1/2 phosphorylation, but
had no effect on expression of Bglap2 or Ibsp mRNAs. Only after
wild-type RUNX2 was transfected into cells did they acquire the
ability to respond to FFSS in an osteoblast-appropriate manner
(eg, induction of Bglap2 and Ibsp mRNAs). Thus, RUNX2 is
Fig. 7. Proposed mechanism for regulation of osteoblast gene expression by mechanical loading. In the unstimulated state, RUNX2 is bound to specific
enhancer regions in the chromatin of target genes. Mechanical loading of bones exposes cells to fluid flow shear stress (FFSS), which activates focal
adhesion kinase (FAK) in focal adhesions adjacent to extracellular matrix–cell contact points. FAK activates ERK/MAPK signaling, leading to nuclear
translocation of P-ERK. In the nucleus, P-ERK docks to specific binding sites on RUNX2, where it phosphorylates this transcription factor at specific serine
residues including S301 and S319. RUNX2-P recruits accessory nuclear factors, including histone acetyltransferases and possibly other protein kinases, to
chromatin, leading to histone phosphorylation, acetylation, and decondensation, thereby allowing transcription of osteoblast-related genes.
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necessary for P-ERK to activate an osteoblast-selective transcrip-
tional program. Furthermore, this activation requires RUNX2
phosphorylation because the RUNX2 S301A, S319A double
mutant was refractory to MAPK activation.
There is now considerable evidence in support of the concept
that tissue-specific transcription factors can serve as docking
sites for nuclear kinases. For example, in muscle regeneration,
the tissue-specific transcription factors, MyoD andMEF2, serve as
docking sites for p38a/b on the chromatin of muscle-related
genes. Subsequent p38-related phosphorylation is necessary for
histone acetylation, chromatin decondensation, and increased
muscle-specific gene expression.(39,40) Also, in pancreatic b cells,
exposure to elevated glucose concentrations stimulates the
binding of P-ERK to Beta2, MafA, and PDX-1 transcription factors
on the promoters of several glucose-inducible genes including
insulin, where it initiates recruitment of accessory factors to
stimulate transcription.(41) Of interest, studies in yeast suggest
that the association of protein kinases with chromatin may be a
common phenomenon in eukaryotic cells broad regulatory
implications.(42) Specifically, yeast homologues of p38, ERK, and
PKA all become associated with the chromatin of multiple target
genes, to globally alter patterns of gene expression in response
to several external stimuli such as osmotic stress, pheromones,
or glucose.
In addition to stimulating osteoblast differentiation and
bone formation, dynamic loading of bone can suppress
other mesenchymal lineages such as adipocytes. For example,
exposure of mice to low-magnitude mechanical signals
preferentially increased differentiation of marrow stromal cells
(MSCs) to osteoblasts and decreased adipocyte differen-
tiation.(43) Furthermore, in vitro studies suggest that chronic
exposure of MSCs to uniform biaxial strain, another type of
mechanical signal that uses similar pathways to FFSS, can
reduce the adipogenic potential of these cells.(44) Although
the mechanistic basis for these responses is not known, nuclear
P-ERK could suppress adipogenic genes while stimulating
osteoblast gene expression.(45) A test of the validity of these
concepts will require genomic studies to determine the extent
to which P-ERK associates with RUNX2 on osteoblast-related
genes as well as possible interactions with genes of adipocyte
lineage.
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